Analysis of risk factors influencing outcomes after cord blood transplantation in children with juvenile myelomonocytic leukemia: a EUROCORD, EBMT, EWOG-MDS, CIBMTR study.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Blood

• Publication date

  2010-11-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/blood-2013-03-491589PMID 23926304PMCID PMC3836039
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Outcomes of immunological interventions for mixed chimerism following allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia

  2013cited by this paper
• Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome.

  2011cited by this paper
• transplants in children with acute leukemia Comparison of outcomes of unrelated bone marrow and umbilical cord blood

  2011cited by this paper
• Gene expression-based classification as an independent predictor of clinical outcome in juvenile myelomonocytic leukemia.

  2010cited by this paper
• Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia

  2010cited by this paper
• Molecular basis of juvenile myelomonocytic leukemia

  2010cited by this paper
• Searching for alternative hematopoietic stem cell donors for pediatric patients

  2008cited by this paper
• Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies.

  2008cited by this paper
• Graft versus leukemia effect against juvenile myelomonocytic leukemia after unrelated cord blood transplantation

  2008cited by this paper
• HLA-identical umbilical cord blood transplantation from a sibling donor in juvenile myelomonocytic leukemia

  2008cited by this paper
• Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutations.

  2007cited by this paper
• Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study.

  2007cited by this paper
• Hematopoietic Stem Cell Transplantation (HSCT) in Children With Juvenile Myelomonocytic Leukemia (JMML): Results of the EWOG-MDS/EBMT Trial

  2006cited by this paper
• Cord blood transplantation.

  2006cited by this paper
• Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial.

  2005cited by this paper
• Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia

  2003cited by this paper
• Allogeneic hematopoietic stem cell transplantation for 27 children with juvenile myelomonocytic leukemia diagnosed based on the criteria of the International JMML Working Group

  2002cited by this paper
• [Cord blood transplantation].

  2002cited by this paper
• Unrelated donor bone marrow transplantation for children with juvenile myelomonocytic leukaemia

  2002cited by this paper
• Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.

  2001cited by this paper
• Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis.

  2001cited by this paper
• Cord blood transplantation from HLA‐mismatched unrelated donors as a treatment for children with haematological malignancies

  2001cited by this paper
• Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

  1999cited by this paper
• A Proportional Hazards Model for the Subdistribution of a Competing Risk

  1999cited by this paper
• Alternative donor bone marrow transplantation for children with juvenile myelomonocytic leukemia.

  1999cited by this paper
• Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)

  1997cited by this paper
• Chronic myelomonocytic leukemia in childhood. A retrospective analysis of 110 cases.

  1997cited by this paper
• Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood.

  1997cited by this paper
• Matched and mismatched unrelated donor bone marrow transplantation for juvenile chronic myeloid leukaemia

  1996cited by this paper
• Myelodysplastic syndrome in childhood.

  1996cited by this paper
• Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution.

  1995cited by this paper
• Pediatric myelodysplasia: a study of 68 children and a new prognostic scoring system.

  1995cited by this paper
• Mutations of the N-ras gene in juvenile chronic myelogenous leukemia.

  1994cited by this paper
• Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders.

  1994cited by this paper
• Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings.

  1983cited by this paper
• CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S

  1974cited by this paper
• Regression Models and Life-Tables

  year unknowncited by this paper

• Indications for haematopoietic cell transplantation and CAR-T for haematological diseases, solid tumours and immune disorders: 2025 EBMT practice recommendations

  2025cites this paper
• A novel conditioning regimen involving haploid immune cell infusion combined with umbilical cord blood transplantation for the treatment of juvenile myelomonocytic leukemia

  2025cites this paper
• Juvenile myelomonocytic leukemia stem cells are sensitive to NK cell–mediated lysis and express targetable antigens

  2025cites this paper
• Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology Group.

  2024cites this paper
• A predictive classifier of poor prognosis in transplanted patients with juvenile myelomonocytic leukemia: a study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire

  2024cites this paper
• Droplet digital PCR: An effective method for monitoring and prognostic evaluation of minimal residual disease in JMML

  2024cites this paper
• Prime editing: A gene precision editing tool from inception to present

  2024cites this paper
• Decitabine-based treatment strategy improved the outcome of HSCT in JMML: a retrospective cohort study

  2024cites this paper
• Monosomy 7/del(7q) cause sensitivity to inhibitors of nicotinamide phosphoribosyltransferase in acute myeloid leukemia

  2023cites this paper
• Natural history of Ras‐associated autoimmune leukoproliferative disorder: A 20‐year follow‐up of a NRAS‐mutated patient excluding a malignant progression

  2023cites this paper
• A successful second allogeneic hematopoietic stem cell transplantation from an alternative donor in a patient with loss of HLA heterozygosity relapse of juvenile myelomonocytic leukemia: case series analysis

  2023cites this paper
• Children's Oncology Group's 2023 blueprint for research: Cellular therapy and stem cell transplantation

  2023cites this paper
• [Juvenile myelomonocytic leukemia and pediatric myelodysplastic syndromes].

  2023cites this paper
• Leucémies myélo-monocytaires juvéniles et syndromes myélodysplasiques de l’enfant

  2023cites this paper
• Response to chemotherapy in juvenile myelomonocytic leukemia and its clinical implications for survival: A retrospective registry-based study of the Korean Pediatric Hematology-Oncology Group.

  2023cites this paper
• Features of Epstein–Barr Virus and Cytomegalovirus Reactivation in Acute Leukemia Patients After Haplo-HCT With Myeloablative ATG-Containing Conditioning Regimen

  2022cites this paper
• Allogeneic hematopoietic cell transplantation in patients with juvenile myelomonocytic leukemia in Korea: a report of the Korean Pediatric Hematology-Oncology Group

  2022cites this paper
• Allogeneic Hematopoietic Stem Cell Transplantation for Mixed or Overlap Myelodysplastic/Myeloproliferative Disorders

  2022cites this paper
• Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022

  2022cites this paper
• Prenatal Origin of Pediatric Leukemia: Lessons From Hematopoietic Development

  2021cites this paper
• Juvenile Myelomonocytic Leukemia and other myelodysplastic/myeloproliferative neoplasms

  2021cites this paper
• Clinical outcome of cord blood transplantation for nine children with juvenile myelomonocytic leukemia receiving fludarabine‐busulfan‐cyclophosphamide‐based conditioning

  2021cites this paper
• Radiation-sparing reduced-intensity unrelated umbilical cord blood transplantation for rare hematological disorders in children

  2021cites this paper
• Data Unit, Translational Research, and Registries

  2021cites this paper
• A retrospective analysis of azacitidine treatment for juvenile myelomonocytic leukemia

  2021cites this paper
• 6-Mercaptopurine to Induce Remission Despite Graft Failure Post Hematopoietic Cell Transplantation for Juvenile Myelomonocytic Leukemia.

  2021cites this paper
• Characteristics of RAS pathway mutations in juvenile myelomonocytic leukaemia: a single‐institution study from Korea

  2021cites this paper
• Juvenile myelomonocytic leukemia in the molecular era: a clinician’s guide to diagnosis, risk stratification, and treatment

  2021cites this paper
• Donor KIR Gene Content and KIR-Ligand Matching and Outcomes of Pediatric Patients with JMML Following Unrelated Donor Transplant.

  2021cites this paper
• Current Treatment of Juvenile Myelomonocytic Leukemia

  2021cites this paper
• Genome editing approaches to β-hemoglobinopathies.

  2021cites this paper
• Juvenile myelomonocytic leukemia-A comprehensive review and recent advances in management.

  2021cites this paper
• Pediatric Neoplasms Presenting with Monocytosis

  2021cites this paper
• Base and Prime Editing Technologies for Blood Disorders

  2021cites this paper
• Outcomes of juvenile myelomonocytic leukemia patients after sequential therapy with cytarabine and 6-mercaptopurine

  2020cites this paper
• Combination of DNA-hypomethylating agent and hematopoietic stem cell transplantation in treatment of juvenile myelomonocytic leukemia

  2020cites this paper
• After 95 years, it's time to eRASe JMML.

  2020cites this paper
• Human leukocyte antigen disparities reduce relapse after hematopoietic stem cell transplantation in children with juvenile myelomonocytic leukemia: A single‐center retrospective study from China

  2020cites this paper
• Cord blood transplantation for acute leukemia

  2020cites this paper
• Hematopoietic stem cell transplantation and cellular therapy in sickle cell disease: where are we now?

  2019cites this paper
• Successful hematopoietic stem cell transplantation from an HLA‐mismatched parent for engraftment failure after unrelated cord blood transplantation in patients with juvenile myelomonocytic leukemia: Report of two cases

  2019cites this paper
• Essentials of Hematology

  2019cites this paper
• Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019

  2019cites this paper
• Molecular assessment of pretransplant chemotherapy in the treatment of juvenile myelomonocytic leukemia

  2019cites this paper
• Current status of umbilical cord blood transplantation in children

  2019influential citation
• Clinical outcomes after allogeneic hematopoietic stem cell transplantation in children with juvenile myelomonocytic leukemia: A report from the Japan Society for Hematopoietic Cell Transplantation.

  2019cites this paper
• PTPN11 mutation with additional somatic alteration indicates unfavorable outcome in juvenile myelomonocytic leukemia: a retrospective clinical study from a single center

  2019cites this paper
• The results of hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia at the Russian Children’s Clinical Hospital

  2019cites this paper
• Hematopoietic-restricted Ptpn11E76K reveals indolent MPN progression in mice

  2018cites this paper
• JMML genomics and decisions.

  2018cites this paper
• Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia

  2018cites this paper
• Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study

  2018cites this paper
• Pediatric MDS Including Refractory Cytopenia and Juvenile Myelomonocytic Leukemia

  2018cites this paper
• [Advances in the treatment of juvenile myelomonocytic leukemia].

  2018cites this paper
• Rare Hematological Malignancies in Children

  2017cites this paper
• Yolk sac erythromyeloid progenitors expressing gain of function PTPN11 have functional features of JMML but are not sufficient to cause disease in mice

  2017cites this paper
• DNA-hypomethylating agents as epigenetic therapy before and after allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and juvenile myelomonocytic leukemia.

  2017cites this paper
• Current concepts on hematopoietic stem cell transplantation outcome registries; Emphases on resource requirements for new registries.

  2017cites this paper
• Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation.

  2017cites this paper
• Cord Blood Transplants for Myeloid Malignancies in Children

  2017cites this paper
• Mice expressing KrasG12D in hematopoietic multipotent progenitor cells develop neonatal myeloid leukemia.

  2017cites this paper
• Myelodysplastic Syndrome (MDS) and Juvenile Myelomonocytic Leukemia (JMML)

  2017cites this paper
• Yolk Sac Erythromyeloid Progenitors Expressing Gain Of Function PTPN 11 Have Functional Features Of JMML But Are Not Sufficient To Cause Disease In Mice Running title : PTPN 11 Mutations in Yolk Sac Erythromyeloid Progenitors

  2017cites this paper
• Umbilical cord blood cells from unrelated donor as an alternative source of hematopoietic stem cells for transplantation in children and adults.

  2016cites this paper
• Hematopoietic Cell Transplantation for Juvenile Myelomonocytic Leukemia

  2016cites this paper
• Impact of Graft-Recipient ABO Compatibility on Outcomes after Umbilical Cord Blood Transplant for Nonmalignant Disease.

  2016cites this paper
• Diagnosis and treatment of juvenile myelomonocytic leukemia

  2016cites this paper
• Novel Pharmacotherapies for B-Cell Lymphomas and Leukemias

  2016cites this paper
• Transplantation for juvenile myelomonocytic leukemia: a retrospective study of 30 children treated with a regimen of busulfan, fludarabine, and melphalan

  2015cites this paper
• How I treat juvenile myelomonocytic leukemia.

  2015influential citation
• Increasing prevalence of thalassemia in America: Implications for primary care

  2015cites this paper
• Different aspects of stem cell procedures in children with poor responding AML: when is HSCT the best answer?

  2015cites this paper
• Pediatric myelodysplastic/myeloproliferative neoplasms and related diseases

  2015cites this paper
• Clinical Use of Umbilical Cord Blood Cells

  2015cites this paper
• Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015

  2015cites this paper
• Improved outcomes associated with hematopoietic stem cell transplantation for patients with juvenile myelomonocytic leukemia.

  2015cites this paper
• Preventing stem cell transplantation-associated viral infections using T-cell therapy.

  2015cites this paper
• Interpreting outcome data in hematopoietic cell transplantation for leukemia: tackling common biases

  2015cites this paper
• Subclonal mutations in SETBP1 confer a poor prognosis in juvenile myelomonocytic leukemia.

  2015cites this paper
• Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia

  2015cites this paper
• Juvenile myelomonocytic leukemia.

  2015cites this paper
• Successful second unrelated cord blood transplantation in a child with juvenile myelomonocytic leukemia

  2014cites this paper
• Cord Blood Transplantation for Pediatric Hematologic Malignancies: Indications, Mechanisms, and Outcomes

  2014cites this paper
• Bedside to bench in juvenile myelomonocytic leukemia: insights into leukemogenesis from a rare pediatric leukemia.

  2014cites this paper
• Cytosine Arabinoside and Mitoxantrone Followed by Second Allogeneic Transplant for the Treatment of Children With Refractory Juvenile Myelomonocytic Leukemia

  2014cites this paper
• RAS diseases in children

  2014cites this paper
• Juvenile Myelomonocytic Leukemia: Molecular Pathogenesis Informs Current Approaches to Therapy and Hematopoietic Cell Transplantation

  2014influential citation
• Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries experts

  2014cites this paper
• [Juvenile myelomonocytic leukemias].

  2014cites this paper
• Studies of specific viruses from Guthrie cards and prognostic markers in bone marrow samples from children diagnosed with leukemia

  2014cites this paper
• MYELOID NEOPLASIA Subclonal mutations in SETBP1 confer a poor prognosis in juvenile myelomonocytic leukemia

  2014cites this paper
• An enriched population of CD45, CD34 and CD117 stem cells in human umbilical cord blood for potential therapeutic regenerative strategies.

  2014cites this paper
• −7/7q− syndrome in myeloid-lineage hematopoietic malignancies: attempts to understand this complex disease entity

  2014cites this paper
• Successful double umbilical cord blood transplantation for relapsed juvenile myelomonocytic leukemia

  2013cites this paper